Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1849 1
1855 1
1867 1
1871 1
1875 1
1878 1
1880 1
1884 1
1890 1
1892 3
1895 1
1901 1
1902 1
1903 3
1906 1
1908 2
1910 1
1911 1
1913 4
1914 5
1915 2
1916 1
1917 1
1920 3
1922 3
1923 3
1924 1
1925 1
1926 2
1927 1
1928 1
1929 3
1930 2
1933 2
1934 1
1935 2
1936 2
1937 2
1938 1
1939 4
1940 1
1941 2
1942 2
1943 1
1944 4
1945 55
1946 219
1947 254
1948 270
1949 167
1950 53
1951 67
1952 162
1953 1210
1954 1649
1955 1874
1956 1705
1957 1883
1958 1735
1959 847
1960 135
1961 124
1962 168
1963 395
1964 791
1965 3646
1966 6143
1967 7043
1968 7706
1969 8892
1970 10103
1971 10742
1972 11584
1973 12536
1974 12872
1975 12858
1976 13849
1977 13893
1978 14598
1979 15356
1980 15187
1981 16147
1982 17749
1983 18951
1984 19893
1985 20662
1986 21223
1987 22077
1988 23367
1989 26082
1990 28225
1991 28777
1992 29401
1993 31513
1994 32815
1995 33892
1996 35233
1997 36199
1998 37587
1999 39151
2000 41612
2001 45556
2002 49383
2003 51580
2004 52893
2005 56515
2006 62437
2007 66923
2008 71592
2009 76464
2010 83044
2011 90144
2012 94268
2013 99038
2014 102385
2015 104269
2016 105086
2017 109720
2018 114846
2019 117523
2020 129808
2021 135387
2022 137932
2023 128826
2024 135712
2025 133444
2026 1768

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,817,721 results

Results by year

Filters applied: . Clear all
Page 1
Overview of late-onset psychoses.
Devanand DP, Jeste DV, Stroup TS, Goldberg TE. Devanand DP, et al. Int Psychogeriatr. 2024 Jan;36(1):28-42. doi: 10.1017/S1041610223000157. Epub 2023 Mar 3. Int Psychogeriatr. 2024. PMID: 36866576 Free article. Review.
Delusions and hallucinations are common in Alzheimer's disease, and hallucinations are common in Parkinson's disease and Lewy body dementia. Psychosis in dementia is associated with increased agitation and a poor prognosis. Although commonly use …
Delusions and hallucinations are common in Alzheimer's disease, and hallucinations are common in Parkinson's disease an …
Implications of Adverse Outcomes Associated with Antipsychotics in Older Patients with Dementia: A 2011-2022 Update.
Rogowska M, Thornton M, Creese B, Velayudhan L, Aarsland D, Ballard C, Tsamakis K, Stewart R, Mueller C. Rogowska M, et al. Drugs Aging. 2023 Jan;40(1):21-32. doi: 10.1007/s40266-022-00992-5. Epub 2022 Dec 14. Drugs Aging. 2023. PMID: 36513918 Free PMC article. Review.
The aim of this review is to provide an update on findings on adverse outcomes and clinical implications of antipsychotic use in dementia. These medications may increase mortality and can be associated with adverse events including pneumonia, cerebrovascular events, …
The aim of this review is to provide an update on findings on adverse outcomes and clinical implications of antipsychotic use in dementia …
Management of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panel.
Kales HC, Gitlin LN, Lyketsos CG; Detroit Expert Panel on Assessment and Management of Neuropsychiatric Symptoms of Dementia. Kales HC, et al. J Am Geriatr Soc. 2014 Apr;62(4):762-9. doi: 10.1111/jgs.12730. Epub 2014 Mar 17. J Am Geriatr Soc. 2014. PMID: 24635665 Free PMC article. Review.
Noncognitive neuropsychiatric symptoms (NPS) of dementia (aggression, agitation, depression, anxiety, delusions, hallucinations, apathy, disinhibition) affect individuals with dementia nearly universally across dementia stages and etiologies. ...Although the …
Noncognitive neuropsychiatric symptoms (NPS) of dementia (aggression, agitation, depression, anxiety, delusions, hallucinations, apat …
Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia.
Davies SJ, Burhan AM, Kim D, Gerretsen P, Graff-Guerrero A, Woo VL, Kumar S, Colman S, Pollock BG, Mulsant BH, Rajji TK. Davies SJ, et al. J Psychopharmacol. 2018 May;32(5):509-523. doi: 10.1177/0269881117744996. Epub 2018 Jan 17. J Psychopharmacol. 2018. PMID: 29338602 Free PMC article.
INTRODUCTION: Behavioural and psychological symptoms of dementia (BPSD) include agitation and aggression in people with dementia. BPSD is common on inpatient psychogeriatric units and may prevent individuals from living at home or in residential/nursing home setting …
INTRODUCTION: Behavioural and psychological symptoms of dementia (BPSD) include agitation and aggression in people with dementia …
Dementia.
Cunningham EL, McGuinness B, Herron B, Passmore AP. Cunningham EL, et al. Ulster Med J. 2015 May;84(2):79-87. Ulster Med J. 2015. PMID: 26170481 Free PMC article. Review.
The clinical syndrome of dementia can be due to a variety of underlying pathophysiological processes. The most common of these is Alzheimer's disease (50-75%) followed by vascular dementia (20%), dementia with Lewy bodies (5%) and frontot …
The clinical syndrome of dementia can be due to a variety of underlying pathophysiological processes. The most common of these is …
Effect of diabetes medications on the risk of developing dementia, mild cognitive impairment, or cognitive decline: A systematic review and meta-analysis.
Hui EK, Mukadam N, Kohl G, Livingston G. Hui EK, et al. J Alzheimers Dis. 2025 Apr;104(3):627-648. doi: 10.1177/13872877251319054. Epub 2025 Feb 27. J Alzheimers Dis. 2025. PMID: 40017057 Free PMC article.
Background: Diabetes is a risk factor for dementia, but we do not know whether specific diabetes medications ameliorate this risk. Objective: To systematically review and meta-analyze such medication's effect on the risk of developing dementia, mild cognitive …
Background: Diabetes is a risk factor for dementia, but we do not know whether specific diabetes medications ameliorate this r …
C-reactive protein-mediated dementia.
Tang JM, Lu Q, Lin HX, Li JQ, Zhu XC, Ma T. Tang JM, et al. Psychogeriatrics. 2025 May;25(3):e70032. doi: 10.1111/psyg.70032. Psychogeriatrics. 2025. PMID: 40194896 Review.
Loss of memory is the main feature of dementia, accompanied by personality changes. Alzheimer's disease (AD) is the most prevalent type of dementia globally and a major contributor to disability and mortality in older individuals. Most notably, …
Loss of memory is the main feature of dementia, accompanied by personality changes. Alzheimer's disease (AD) is …
[Agitation].
Yoshiyama K. Yoshiyama K. Brain Nerve. 2025 Nov;77(11):1231-1240. doi: 10.11477/mf.188160960770111231. Brain Nerve. 2025. PMID: 41233181 Japanese.
Agitation is a behavioral and psychological symptom of dementia (BPSD); however, until recently, there has been no consensus-based definition. ...Brexpiprazole has been approved as effective for agitation in Alzheimer's disease. For the treatment of ag …
Agitation is a behavioral and psychological symptom of dementia (BPSD); however, until recently, there has been no consensus-based de …
Ginkgo biloba.
Sierpina VS, Wollschlaeger B, Blumenthal M. Sierpina VS, et al. Am Fam Physician. 2003 Sep 1;68(5):923-6. Am Fam Physician. 2003. PMID: 13678141 Free article. Review.
Ginkgo biloba is commonly used in the treatment of early-stage Alzheimer's disease, vascular dementia, peripheral claudication, and tinnitus of vascular origin. Multiple trials investigating the efficacy of ginkgo for treating cerebrovascular disease a …
Ginkgo biloba is commonly used in the treatment of early-stage Alzheimer's disease, vascular dementia, periphera …
Ginkgo biloba: A Leaf of Hope in the Fight against Alzheimer's Dementia: Clinical Trial Systematic Review.
Pagotto GLO, Santos LMOD, Osman N, Lamas CB, Laurindo LF, Pomini KT, Guissoni LM, Lima EP, Goulart RA, Catharin VMCS, Direito R, Tanaka M, Barbalho SM. Pagotto GLO, et al. Antioxidants (Basel). 2024 May 27;13(6):651. doi: 10.3390/antiox13060651. Antioxidants (Basel). 2024. PMID: 38929090 Free PMC article. Review.
Alzheimer's disease (AD) is a stealthy and progressive neurological disorder that is a leading cause of dementia in the global elderly population, imposing a significant burden on both the elderly and society. ...A systematic search across three databa …
Alzheimer's disease (AD) is a stealthy and progressive neurological disorder that is a leading cause of dementia …
2,817,721 results
You have reached the last available page of results. Please see the User Guide for more information.